Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-22T07:13:48.593Z Has data issue: false hasContentIssue false

Chlormethiazole and Trifluoperazine in Alcohol Withdrawal

Published online by Cambridge University Press:  29 January 2018

J. S. Madden
Affiliation:
Addiction Unit, Moston Hospital, Chester
D. Jones
Affiliation:
Alder Hey Children's Hospital, Liverpool 14
E. P. Frisch
Affiliation:
Department of Clinical Investigations and Medical Statistics, Laboratories Division, AB Astra, Södertölje, Sweden

Extract

Chlormethiazole (Heminevrin) is a sedative and anticonvulsant that has been reported by Glatt et al. (1965) to be more effective than placebo for the alcohol abstinence syndrome. The present study was designed to compare the substance with trifluoperazine (Stelazine).

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1969 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Detre, T., and Feldman, R. G. (1963). ‘Behaviour disorder associated with seizure states: pharmacological and psychosocial management,’ in E.E.G. and Behaviour (ed. Glasser, G. H.). New York: Basic Books.Google Scholar
Glatt, M. M., George, H. R., and Frisch, E. P. (1965). ‘Controlled trial of chlormethiazole in treatment of the alcohol withdrawal phase.’ Brit. med. J., 2, 401–4.Google Scholar
Lundquist, G. (1966). ‘The risk of dependence on chlormethiazole.’ Acta psychiat. Scand., Suppl. 192, 203–4.Google Scholar
Quinn, J. T. (1968). Personal communication.Google Scholar
Salum, I. (1963). ‘The clinical use of Heminevrin.’ Nord. psychiat. T., 17, 2029.Google Scholar
Svedin, C. O. (1966). ‘Side effects in chlormethiazole therapy.’ Acta psychiat. Scand., Suppl. 192, 199201.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.